These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 2168934

  • 1. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ, Mulder AH, Schoffelmeer AN.
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [Abstract] [Full Text] [Related]

  • 2. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
    Van Vliet BJ, Ruuls SR, Drukarch B, Mulder AH, Schoffelmeer AN.
    Eur J Pharmacol; 1991 Mar 26; 195(2):295-300. PubMed ID: 1651867
    [Abstract] [Full Text] [Related]

  • 3. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
    Schoffelmeer AN, Hansen HA, Stoof JC, Mulder AH.
    J Neurosci; 1986 Aug 26; 6(8):2235-9. PubMed ID: 3018189
    [Abstract] [Full Text] [Related]

  • 4. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN.
    J Pharmacol Exp Ther; 1989 Jun 26; 249(3):864-8. PubMed ID: 2543814
    [Abstract] [Full Text] [Related]

  • 5. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH, Bakker JM, Hogenboom F, Mulder AH, Schoffelmeer AN.
    Eur J Pharmacol; 1992 Dec 15; 229(2-3):197-202. PubMed ID: 1337044
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
    Van Vliet BJ, De Vries TJ, Wardeh G, Mulder AH, Schoffelmeer AN.
    Eur J Pharmacol; 1991 Oct 14; 208(2):105-11. PubMed ID: 1666051
    [Abstract] [Full Text] [Related]

  • 8. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
    Schoffelmeer AN, De Vries TJ, Hogenboom F, Hruby VJ, Portoghese PS, Mulder AH.
    J Pharmacol Exp Ther; 1992 Oct 14; 263(1):20-4. PubMed ID: 1328606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slices.
    De Vries TJ, Schoffelmeer AN, Delay-Goyet P, Roques BP, Mulder AH.
    Eur J Pharmacol; 1989 Nov 07; 170(3):137-43. PubMed ID: 2575993
    [Abstract] [Full Text] [Related]

  • 11. Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum.
    Schoffelmeer AN, Rice KC, Heijna MH, Hogenboom F, Mulder AH.
    Eur J Pharmacol; 1988 Apr 27; 149(1-2):179-82. PubMed ID: 2840299
    [Abstract] [Full Text] [Related]

  • 12. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC, Onali P.
    Mol Pharmacol; 1992 Jul 27; 42(1):109-15. PubMed ID: 1321951
    [Abstract] [Full Text] [Related]

  • 13. Effect of opioid agonists selective for three subclasses of opioid receptors and one sigma receptor agonist on dopamine stimulated adenylate cyclase in rat caudate nucleus.
    Grynne BH, Holmen AT, Enger M, Maurset AR.
    Pharmacol Toxicol; 1991 Nov 27; 69(5):338-40. PubMed ID: 1666431
    [Abstract] [Full Text] [Related]

  • 14. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
    De Vries TJ, Hogenboom F, Mulder AH, Schoffelmeer AN.
    Brain Res Dev Brain Res; 1990 Jun 01; 54(1):63-9. PubMed ID: 2163782
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN, Hansen HA, Stoof JC, Mulder AH.
    Eur J Pharmacol; 1985 Dec 03; 118(3):363-6. PubMed ID: 2417870
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
    Arenas E, Alberch J, Marsal J.
    Neuroscience; 1991 Dec 03; 42(3):707-14. PubMed ID: 1683474
    [Abstract] [Full Text] [Related]

  • 17. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH, Padt M, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN.
    Eur J Pharmacol; 1990 Jun 08; 181(3):267-78. PubMed ID: 2166675
    [Abstract] [Full Text] [Related]

  • 18. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
    Passarelli F, Costa T.
    J Pharmacol Exp Ther; 1989 Jan 08; 248(1):299-305. PubMed ID: 2536429
    [Abstract] [Full Text] [Related]

  • 19. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M, La Regina A, Petrillo P, Tavani A.
    NIDA Res Monogr; 1986 Jan 08; 75():520-3. PubMed ID: 2828999
    [Abstract] [Full Text] [Related]

  • 20. Mu and delta opiate receptors in neuronal and astroglial primary cultures from various regions of the brain--coupling with adenylate cyclase, localisation on the same neurones and association with dopamine (D1) receptor adenylate cyclase.
    Eriksson PS, Hansson E, Rönnbäck L.
    Neuropharmacology; 1991 Nov 08; 30(11):1233-9. PubMed ID: 1663598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.